Amphastar Pharmaceuticals, Inc. (AMPH) compared with its closest peers (SUPN, EBS, CORT, RARE, COLL): P/E 15.7 vs industry 17.2. Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Supernus Pharmaceuticals, Emergent BioSolutions, Corcept Therapeutics, Ultragenyx Pharmaceutical, Collegium Pharmaceutical, Axsome Therapeutics, Arrowhead Pharmaceuticals, TG Therapeutics, OPKO Health and Insmed share Amphastar Pharmaceuticals's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Supernus Pharmaceuticals, Inc. (SUPN) | $2.66B | -73.0 |
| Emergent BioSolutions Inc. (EBS) | $262.37M | 2.3 |
| Corcept Therapeutics Incorporated (CORT) | $13.22B | 42.5 |
| Ultragenyx Pharmaceutical Inc. (RARE) | $2.59B | -3.9 |
| Collegium Pharmaceutical, Inc. (COLL) | $882.75M | 19.4 |
| Axsome Therapeutics, Inc. (AXSM) | $10.88B | -49.7 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | $12.31B | -3453.0 |
| TG Therapeutics, Inc. (TGTX) | $8.31B | 18.7 |
| OPKO Health, Inc. (OPK) | $1.10B | -4.2 |
| Insmed Incorporated (INSM) | $27.47B | -27.1 |
| Stock P/E | 15.7 |
| Sector P/E (Healthcare) | 21.7 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| vs Sector | -27.6% |
| vs Industry | -8.4% |
AMPH overview · AMPH earnings · AMPH financials · AMPH KPIs · AMPH documents · AMPH ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.